KULA, Hawaii, Jan. 10 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") today announced that its utility patent application "Method of Making Phytotherapeutic Hydrosols" has been granted a "Petition To Make Special" by the United States Patent And Trademark Office. "The petition requests that the application be made special under the accelerated examination procedure set forth in M.P.E.P. 708.02 Section XII: Special status for Applications relating to BIOTECHNOLOGY FIELD."
The Company's patent application underlies its Bioresonant Phytotherapeutic product offerings which are currently available, world-wide, through distribution and through the internet at its www.bioponic.com web site and other internet distributors such as Amazon.com and Vocal-care.com.
The patent elucidates a new natural healing modality called Bioresonant Phytotherapeutics, which utilizes the process of tuned sympathetic bioresonance produced in the molecular memory of water molecules, entrained with the phytochemical signature of distilled herbal plants. This process establishes a bioresonant harmonic matrix, which in turn provides healing through optimum bioavailability.
"This is an exciting development for the Company," said Steven M. Schorr, Chairman & CEO - Bioponic Phytoceuticals, Inc. "The opportunity for expedited prosecution of our patent application shortens that wait of patenting and brings the focus of an important intellectual property forward. We believe that this patent, once granted, will provide the Company with a strong ownership position for our Bioresonant Phytotherapeutic products, and will allow us to capture and hold the vast market potential that it addresses."
Bioponic Phytoceuticals is engaged in the development, formulation, production and distribution of Bioresonant Phytotherapeutic and nutraceutical products for sale in the Complementary Alternative Medicine ("CAM") and natural products markets. The Company has developed a new healing modality and several branded product lines currently in distribution (including the nationally recognized natural nasal spray: Flight Spray). Bioponic is presently focused on the production of natural products that are used by consumers to promote health and well-being, and to help prevent disease. www.bioponic.com
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control that could cause actual results or events to differ materially from current expectations.
Contact: Steven M. Schorr, CEO Bioponic Phytoceuticals info@bioponic.com phone: 808-876-1711
Bioponic Phytoceuticals, Inc.CONTACT: Steven M. Schorr, CEO of Bioponic Phytoceuticals,+1-808-876-1711, info@bioponic.com
Web site: http://www.bioponic.com/
